| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Liu,Zhong-Zheng | Chairman | 50.26% | ADIMMUNE CORPORATION |
| Pan,Fei | Director | 50.26% | ADIMMUNE CORPORATION |
| Qiu,Jin-Yi | Director | 50.26% | ADIMMUNE CORPORATION |
| Chen,Jian-Run | Director | 2.23% | WEN TENG INVESTMENT CO., LTD. |
| Zhang,Jia-Qi | Independent Director | 0.00% | |
| Li,Chong-Ji | Independent Director | 0.00% | |
| Ma,Da-Wei | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 39,915 | 43,494 | 188,415 |
| Operating cost | 25,689 | 66,867 | 167,573 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 14,226 | -23,373 | 20,842 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 14,226 | -23,373 | 20,842 |
| Operating expenses | 165,367 | 220,102 | 307,258 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -151,141 | -243,475 | -286,416 |
| Non-operating income and expenses | -14,432 | 5,785 | 19,330 |
| Net profit (loss) before tax | -165,573 | -237,690 | -267,086 |
| Income tax expense (benefits) | 0 | 0 | 0 |
| Net profit (loss) of ongoing business for the current period | -165,573 | -237,690 | -267,086 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -165,573 | -237,690 | -267,086 |
| Other comprehensive profit (loss), net | 8,340 | -38 | -4,836 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -157,233 | -237,728 | -271,922 |
| Net profit (loss) attributable to owners of parent company | -157,546 | -223,743 | -247,963 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -8,027 | -13,947 | -19,123 |
| Comprehensive profit (loss) attributable to owners of parent company | -152,959 | -226,272 | -248,115 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -4,274 | -11,456 | -23,807 |
| Basic earnings per share (yuan) | -2 | -3 | -3 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -143,776 | -138,133 | -200,636 |
| Net cash inflows (outflows) from investing activities | -3,639 | 87,858 | 99,936 |
| Net cash inflow (outflow) from financing activities | 264,087 | 16,032 | 381,077 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 8,340 | -38 | -4,588 |
| Increase (decrease) in cash and cash equivalents in the current period | 125,012 | -34,281 | 275,789 |
| Beginning balance of cash and cash equivalents | 359,893 | 394,174 | 118,385 |
| Ending balance of cash and cash equivalents | 484,905 | 359,893 | 394,174 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 588,040 | 465,214 | 627,869 |
| Non-current asset | 135,656 | 139,613 | 147,221 |
| Total asset | 723,696 | 604,827 | 775,090 |
| Current liability | 239,710 | 171,704 | 103,951 |
| Non-current liability | 4,784 | 1,759 | 5,732 |
| Total liability | 244,494 | 173,463 | 109,683 |
| share capital | 721,340 | 658,000 | 658,000 |
| Equity - secruity token | - | - | - |
| capital reserve | 160,641 | 11,559 | 168,023 |
| retained earning | -509,823 | -344,926 | -281,332 |
| Other equity | 1,906 | -2,681 | -152 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 374,064 | 321,952 | 544,539 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 105,138 | 109,412 | 120,868 |
| Total Equity | 479,202 | 431,364 | 665,407 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 5 | 4 | 8 |
